Europe — EMA
Olanzapine Accord
Olanzapine, the active ingredient in Olanzapine Accord, is an atypical antipsychotic presented as a 10 mg tablet for oral use. It treats schizophrenia and bipolar I disorder in adults and adolescents.
Request sourcing
What is Olanzapine?
Olanzapine, the active ingredient in Olanzapine Accord, is an atypical antipsychotic presented as a 10 mg tablet for oral use. It treats schizophrenia and bipolar I disorder in adults and adolescents. GNH USA supplies Olanzapine Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
GNH USA supplies Olanzapine Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
What is Olanzapine used for?
Olanzapine Accord is an atypical antipsychotic that modulates dopamine and serotonin pathways in several psychiatric conditions.
- Schizophrenia: helps reduce positive and negative symptoms and prevents relapse. - Bipolar I disorder (manic episodes): assists with mood stabilization and reduces manic symptoms. - Schizoaffective disorder: improves psychotic and mood components of the illness.
What are the side effects of Olanzapine?
Common Side Effects: - Weight gain - Sedation - Dry mouth - Constipation - Increased appetite - Dizziness
Serious or Rare Side Effects: - Neuroleptic malignant syndrome - Tardive dyskinesia - Hyperglycaemia and new‑onset diabetes mellitus - Orthostatic hypotension - Seizures - Elevated L‑
What precautions apply to Olanzapine?
Olanzapine Accord may … … …
- ... ... - … … ... - … … ...
